Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Buy
57
MDGL Quote, Financials, Valuation and Earnings
Last price:
$341.51
Seasonality move
:
6.27%
Day range:
$330.03 - $344.19
52-week range:
$189.00 - $377.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.00x
Volume:
271.8K
Avg. volume:
396.5K
1-year change:
33.83%
Market cap:
$7.5B
Revenue:
$180.1M
EPS (TTM):
-$22.11
Earnings Data
Next earnings date for MDGL
May 07
2025
Most recent earnings per share
-$2.71
Beat by $1.41
(Feb 26/2025)
Consensus Estimate
-$4.12
(Feb 26/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MDGL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2025 | Q1 | $112.8M | -- | -- | -$3.76 | -- |
| 02/26/2025 | Q4 | $97.8M | $103.3M | -$2.71 | -$4.12 | $1.41 |
| 10/31/2024 | Q3 | $34.4M | $62.2M | -$4.92 | -$6.91 | $1.99 |
| 08/07/2024 | Q2 | $4.4M | $14.6M | -$7.10 | -$7.66 | $0.56 |
| 05/07/2024 | Q1 | -- | -- | -$7.38 | -$6.39 | -$0.99 |
| 02/28/2024 | Q4 | -- | -- | -$5.72 | -$5.34 | -$0.38 |
| 11/06/2023 | Q3 | -- | -- | -$5.34 | -$4.93 | -$0.41 |
| 08/08/2023 | Q2 | -- | -- | -$4.69 | -$4.54 | -$0.15 |
| 05/09/2023 | Q1 | -- | -- | -$4.23 | -$4.78 | $0.55 |
| 02/23/2023 | Q4 | -- | -- | -$4.98 | -$4.61 | -$0.37 |
| 11/03/2022 | Q3 | -- | -- | -$4.75 | -$4.18 | -$0.57 |
| 08/04/2022 | Q2 | -- | -- | -$4.14 | -$3.64 | -$0.50 |
| 05/09/2022 | Q1 | -- | -- | -$3.36 | -$3.54 | $0.18 |
| 02/24/2022 | Q4 | -- | -- | -$3.78 | -$3.91 | $0.13 |
| 11/04/2021 | Q3 | -- | -- | -$3.79 | -$3.85 | $0.06 |
| 08/05/2021 | Q2 | -- | -- | -$3.72 | -$3.54 | -$0.18 |
| 05/06/2021 | Q1 | -- | -- | -$3.32 | -$3.89 | $0.57 |
| 02/25/2021 | Q4 | -- | -- | -$3.82 | -$3.90 | $0.08 |
| 11/05/2020 | Q3 | -- | -- | -$3.75 | -$3.30 | -$0.45 |
| 08/06/2020 | Q2 | -- | -- | -$3.18 | -$2.43 | -$0.75 |
| 05/07/2020 | Q1 | -- | -- | -$2.34 | -$1.95 | -$0.39 |
| 02/26/2020 | Q4 | -- | -- | -$1.80 | -$1.67 | -$0.13 |
| 11/06/2019 | Q3 | -- | -- | -$1.39 | -$1.42 | $0.03 |
| 08/07/2019 | Q2 | -- | -- | -$1.28 | -$1.22 | -$0.06 |
| 05/08/2019 | Q1 | -- | -- | -$0.98 | -$0.97 | -$0.01 |
| 02/27/2019 | Q4 | -- | -- | -$0.76 | -$0.74 | -$0.02 |
| 11/06/2018 | Q3 | -- | -- | -$0.56 | -$0.53 | -$0.03 |
| 08/07/2018 | Q2 | -- | -- | -$0.45 | -$0.62 | $0.17 |
| 04/13/2018 | Q1 | -- | -- | -$0.45 | -$0.77 | $0.32 |
| 12/31/2017 | Q4 | -- | -- | -$0.67 | -$0.70 | $0.03 |
| 11/09/2017 | Q3 | -- | -- | -$0.68 | -$0.79 | $0.11 |
| 08/10/2017 | Q2 | -- | -- | -$0.69 | -$0.60 | -$0.09 |
| 04/03/2017 | Q1 | -- | -- | -$0.50 | -$0.87 | $0.37 |
Madrigal Pharmaceuticals Earnings Questions
-
How Much did Madrigal Pharmaceuticals Generate in Revenue Last Quarter?
Madrigal Pharmaceuticals reported $103.3M worth of top line sales in its most recent quarter.
-
Did Madrigal Pharmaceuticals Beat Earnings Last Quarter?
Madrigal Pharmaceuticals announced earnings per share of -$2.71 which represents a beat of analyst forecast a -$4.12 per share.
-
Is Madrigal Pharmaceuticals Profitable?
Madrigal Pharmaceuticals reported $99.9M that represents $4.55 per share over the last quarter.
-
What is the Analyst Consensus for Madrigal Pharmaceuticals EPS Next Year?
Madrigal Pharmaceuticals's earnings are forecast to decrease from -$21.90 per share to -$23.47 per share next year representing a decrease of -42.55%.
-
When is Madrigal Pharmaceuticals's Earnings Date?
Madrigal Pharmaceuticals's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
